The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Benzylthio-4-chloro-5-{5-[(4-phenylpiperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}benzenesulfonamide ID: ALA4097199
PubChem CID: 137658963
Max Phase: Preclinical
Molecular Formula: C26H26ClN5O3S2
Molecular Weight: 556.11
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1cc(-c2nnc(CN3CCN(c4ccccc4)CC3)o2)c(Cl)cc1SCc1ccccc1
Standard InChI: InChI=1S/C26H26ClN5O3S2/c27-22-16-23(36-18-19-7-3-1-4-8-19)24(37(28,33)34)15-21(22)26-30-29-25(35-26)17-31-11-13-32(14-12-31)20-9-5-2-6-10-20/h1-10,15-16H,11-14,17-18H2,(H2,28,33,34)
Standard InChI Key: KXIQOVITXYGBAU-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
19.1380 -20.1615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7335 -19.4558 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.3245 -20.1589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6107 -18.2299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6095 -19.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3176 -19.4584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0272 -19.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0244 -18.2263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3158 -17.8211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9029 -17.8215 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.7306 -17.8151 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.7275 -16.9979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4337 -16.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1382 -16.9961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8439 -16.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8412 -15.7674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1270 -15.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4242 -15.7746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9042 -19.4608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1579 -19.1278 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6106 -19.7347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0187 -20.4428 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8181 -20.2734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7980 -19.6486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4662 -18.9018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4427 -19.0468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9462 -18.2437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6177 -17.4994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8051 -17.4091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3221 -18.0695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6517 -18.8201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4748 -16.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9599 -16.0055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6316 -15.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8184 -15.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3347 -15.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6657 -16.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
8 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
5 19 1 0
21 24 1 0
24 25 1 0
7 2 1 0
2 26 1 0
25 27 1 0
25 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
29 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 556.11Molecular Weight (Monoisotopic): 555.1166AlogP: 4.65#Rotatable Bonds: 8Polar Surface Area: 105.56Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.11CX Basic pKa: 6.19CX LogP: 4.19CX LogD: 4.16Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: -1.97
References 1. Sławiński J, Szafrański K, Pogorzelska A, Żołnowska B, Kawiak A, Macur K, Belka M, Bączek T.. (2017) Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability., 132 [PMID:28364658 ] [10.1016/j.ejmech.2017.03.039 ]